Patent 11100163

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

Current assignee: Mimzi, LLC

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

There are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method reviews) on file for U.S. Patent 11,100,163 as of the most recent data ingest and supplementary web searches. This indicates that the patent's claims remain untested by an AIA trial at the PTAB.

Strategic summary

As of the current date, no claims of U.S. Patent 11,100,163 have been subjected to an Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) review at the Patent Trial and Appeal Board (PTAB). Consequently, all claims (1-22) of the '163 patent are currently untested by these AIA trial proceedings.

It is noteworthy that while no AIA trial proceedings were found, web search results indicate that ex parte reexaminations have been filed against U.S. Patent 11,100,163 by Mercedes-Benz AG, as well as against a related patent, U.S. Patent 9,792,361, by both Unified Patents and Mercedes-Benz AG. An ex parte reexamination is a different type of post-grant challenge conducted by a USPTO examiner, distinct from PTAB AIA trial proceedings. The existence of these reexaminations suggests ongoing challenges to the validity of patents within the Mimzi LLC family, but the outcomes of these reexaminations for US11100163 are not yet publicly detailed as Final Written Decisions from PTAB or final certificates from the USPTO.

Recommended next steps

  • No PTAB Activity: Since there is no PTAB activity (IPR, PGR, CBM) on file for U.S. Patent 11,100,163, a defendant facing assertion of this patent would need to initiate their own AIA trial proceeding if they choose to pursue this defensive strategy. The absence of such proceedings means the patent claims have not been challenged or narrowed by the PTAB.
  • Monitor Reexaminations: A defendant should closely monitor the status and outcomes of the ex parte reexamination proceedings initiated by Mercedes-Benz AG against U.S. Patent 11,100,163, as well as those against U.S. Patent 9,792,361. Although these are not PTAB trials, their results could impact the scope and validity of the patent, potentially influencing ongoing or future litigation. Information on these reexaminations can be found through USPTO Public Pair or Patent Center.
  • Prior Art Review: Given the litigation context and the prior art identified in earlier analyses, a thorough review of the prior art (including any newly identified art by Unified Patents) for the specific claims being asserted against a defendant would be a critical initial step. This could inform the basis for a potential new IPR petition.

Generated 5/18/2026, 7:42:22 AM